Found 12 matching trials
Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma PHASE2 This phase II trial investigates the side effects of tocilizumab, ipilimuma...
Show More Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Learn More & Join Trial
TocILizumab in aorTitis in GCA (TILT) N/A This is a french multicenter observational study assessing safety and effic...
Show More Location
Département de Medecine interne et d'immunologie clinique - hôpital La Pitié Salpetrière
Learn More & Join Trial
A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006) PHASE2 Researchers are looking for new ways to treat people with B-cell cancers. I...
Show More Location
Haddasah Medical Center ( Site 0800)
Learn More & Join Trial
Comparison of Complarate® (Tocilizumab Biosimilar) and Actemra® in Patients With Rheumatoid Arthritis PHASE3 This is a randomized double-blind comparative parallel group study of the e...
Show More Location
Limited Liability Company "Family Clinic No. 4"
Learn More & Join Trial
A Safety and Pharmacokinetics Study of Complarate (Tocilizumab Biosimilar Solution) and Actemra® in Healthy Volunteers PHASE1 This is a randomized single-blind comparative parallel group study of the s...
Show More Status
Active Not Recruiting
Location
State budgetary healthcare institution of the city of Moscow "City Clinic No. 2 of the Moscow Health Department"
Learn More & Join Trial
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation PHASE2 The purpose of this clinical trial is to compare drug combinations to learn...
Show More Location
University of Alabama Birmingham
Learn More & Join Trial
A Safety and Pharmacokinetic Study of Complarate (Tocilizumab Biosimilar) and Actemra® in Healthy Volunteers PHASE1 This is a randomized double-blind comparative parallel group study of the s...
Show More Location
Department of Clinical Research, Center for Clinical Drug Research
Learn More & Join Trial
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers PHASE1 The main purpose of this study is to:
* Learn about the safety of ubamatam...
Show More Location
University of Alabama_6th Ave
Learn More & Join Trial
Real World Use of Tocilizumab Biosimilar studY N/A The goal of this non interventional study is to evaluate the use of Tyenne,...
Show More Status
Active Not Recruiting
Location
Rheumatologische Schwerpunktpraxis Berlin
Learn More & Join Trial
Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis PHASE2 Vasculitis occur when the body's immune system, rather than protecting the ...
Show More Location
Cambridge University Hospitals NHS Foundation Trust
Learn More & Join Trial